The 'superbug' methicillin-resistant staphylococcus aureus, or MRSA, is a top concern for hospitals and doctors nationwide. So what are we doing to combat this? Dr. Gian Han, director of Diatherix Laboratories, tells host Bruce Japsen about molecular diagnostic technologies being developed for doctors to detect MRSA and prevent infection in patients.
New Diagnostics to Combat MRSA 'Superbug'
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
The 'superbug' methicillin-resistant staphylococcus aureus, or MRSA, is a top concern for hospitals and doctors nationwide. So what are we doing to combat this? Dr. Gian Han, director of Diatherix Laboratories, tells host Bruce Japsen about molecular diagnostic technologies being developed for doctors to detect MRSA and prevent infection in patients.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
HF Management for Patients with Comorbid Conditions
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?